Marimastat inhibits MMP-2, MMP-9, MMP-1, and other MMPs and, it has been reported to inhibit cancer cell migration 3D in vitro at a 30 μM concentration [41] and to inhibit fibroblast mediated collagen hydrogel contraction at a 10 μM concentration [42]. Here, MMP9 is linked to cancer.